EUA For First At-Home Kit Differentiating COVID-19 From Flu Could Make Difference In Firm’s Survival
Executive Summary
The US FDA has authorized sales of the first at-home test that provides results differentiating flu from COVID. Lucira's EUA for the COVID-19 & Flu Test came two days after the company filed for Chapter 11 bankruptcy protection, indicating it would seek a buyer.
You may also be interested in...
First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.
Bill Steering Hemp In Supplements To NDI Notification Pathway Introduced For Third Time
Virginia Republican Morgan Griffith has same message for FDA he’s previously stated about hemp ingredients. Agency “has dragged its feet in properly regulating CBD and hemp-derived products on the market, creating confusion about its legal uses,” he says.
P&G Looks To Change Children’s Toothpaste Market With Crest Kids Color Changing
Color of the toothpaste, which P&G North America oral care chief says is “only one of its kind on the market today,” changes from blue to pink after two minutes of brushing.